Siemens Healthcare unveiled this week new cardiac imaging software, dubbed syngo Dynamic PET with Myocardial Blood Flow, for its Biograph PET/CT scanners
Siemens unveils coronary PET/CT software
Siemens Healthcare unveiled this week new cardiac imaging software, dubbed syngo Dynamic PET with Myocardial Blood Flow, for its Biograph PET/CT scanners. The new FDA-cleared product, introduced at the American Society for Nuclear Cardiology Scientific Session in Minneapolis, offers a new method for quantitatively evaluating the extent of ischemia via high-performance PET/CT imaging and advanced applications, according to Siemens. Syngo Dynamic PET may have a significant impact on the diagnosis of patients with advanced coronary artery disease, particularly those with multi-vessel disease, or those who are asymptomatic, the company said. Published clinical literature estimates that between 5% and 10% of coronary artery disease patients have balanced vessel disease, and up to 8% are at-risk but asymptomatic. Siemens’ new product may be most valuable to this high-risk group.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.